What They Are Pharmaceutical combination formulation comprising two active pharmaceutical ingredients within one solid dosage form. They may also include pharmaceutical excipients selected according to the formulation details, in suitable quantities.
Combination tablet formulations present challenges to the pharmaceutical developer because the active ingredients may exhibit different physical, chemical and processing properties when present together within the final formulation. Formulation design takes care to consider ingredient compatibility, uniformity, stability, tablet properties and other manufacturing requirements.
Phase 1 development: From raw materials to finished product Tableting begins with sourcing pharmaceutical-grade raw materials, and continues through formulation, processing, compression, testing, packing and storing. Maintaining established standards throughout the process helps the pharmaceutical manufacturer develop a consistent and reproducible finished product.
Composition, Strength & Dose Pharmaceutical excipients can be incorporated during formulation to support powder flow, blending, granulation, compression, tablet strength, physical integrity and other characteristics. A pharmaceutical formulation scientist will evaluate the properties of the individual ingredients, and select excipients and processing steps accordingly. Starting powders or granules can exhibit characteristics such as particle size, flowability, moisture content, compatibility, solubility and stability.
Formulation trials help develop appropriate wetting, blending, granulation, lubrication, compression, disintegration, dissolution and other manufacturing requirements.
As two active pharmaceutical ingredients are present within one finished product, analytical characterization is appropriate to define the quality characteristics of the formulation.
During formulation development, compatibility testing can evaluate the physical stability of the active pharmaceutical ingredients together with other pharmaceutical excipients. Compatibility testing enables formulation scientists to understand the behavior of the final formulation during manufacturing, and may also anticipate their behavior during storage. The physical characteristics of powders or blends can influence manufacturing performance.
Flowability and bendability are important for ensuring that the finished product is similar from batch to batch.
Formulation may be optimized through trials to define appropriate lubricant levels, binder amounts, disintegrant types and levels, granulation techniques, compression forces, and other manufacturing conditions. Once established, the formulation is a key to ensuring the large-scale process is consistent and reproducible from batch to batch.
The processing of Aceclofenac 100mg and Paracetamol 325mg begins after the dispensing of pharmaceutical-grade raw materials. Depending on the processing technology, the process may include steps such as sifting, blending, granulation, drying, lubrication, compression, inspection, and packing.
In-process monitoring helps the manufacturer maintain appropriate parameters, such as blend uniformity, moisture content, weight and thickness. Quality assurance verifies each stage of production, while the quality-control laboratory undertakes analysis such as assay, content uniformity, weight variation, tablet hardness and friability, disintegration and other criteria.
Documentation is another essential element of pharmaceutical production. Batch manufacturing records, component traceability, equipment usage, testing, and finished-product specifications help the pharmaceutical producer supply a consistent product in an organized manner.
The finished product should generally match established specifications for each stage of the production process in order to ensure product consistency.
The physical and chemical stability of the tablet formulation is an important factor to consider during product development. Stability testing may be performed on the finished formulation to assess the physical and chemical stability of the formulation and to inform packaging and storage conditions. Secondary and primary packaging safeguard the product during transportation. Packaging components may be designed to provide protection for the pharmaceutical product, and typically include packaging accounts with product details, composition, strengths, and manufacturing information.
Designs account of the product name, composition, strengths, batch identifier, manufacturing date, expiry date, and packaging details, and may include additional product details. Packaging may also incorporate a branding or identity presentation for the pharmaceutical developer.
Pharmaceutical Portfolio & Position In commercial terms, the finished pharmaceutical product can be positioned within a diverse portfolio of products that include other formulations, strengths, and combination products. Portfolio positioning involves assessing the manufacturing quality, physical characteristics, packaging, packaging accounts, product performance and supply schedules.
Maintaining an assured supply chain is important for production capacity and distribution. Standard and reliable manufacturer schedules and testing, together with inventory planning, support portfolio development.
For those engaged in developing their pharmaceutical portfolio, cooperation with a quality-oriented pharmaceutical manufacturer enables pharmaceutical companies to develop a dependable product range.
The overall quality of the Aceclofenac 100mg + Paracetamol 325mg formulation depends on the management of the raw-material procurement, formulation, processing, testing and packaging stages of the pharmaceutical process.
A quality-specific production approach incorporates pharmaceutical-grade raw materials, controlled environment, documented procedures, dedicated equipment and trained operators, and key checks that support the production of a consistent product batch after batch.
Assay, content uniformity, tablet appearance and uniformity, tablet weight, hardness, friability, disintegration and stability are typical of the quality attributes that can be stressed to produce an excellent finished product. Manufacturers can maintain transparent production throughout the various steps to support their portfolio strategy.
We combine quality, innovation, and strong distribution to help our partners grow successfully in the pharma market.
The company is offering business opportunity for scalable and sustainable returns to its associates. We are engaged in discovery, development and commercialization of pharmaceutical medicine keeping in mind its quality and affordability.
© Novolilly 2025. All Rights Reserved – Developed & Managed By Kavir Infotech